Virtus ETF Advisers LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$342,790
+31.2%
3,362
+17.0%
0.20%
+41.0%
Q1 2023$261,304
+73.0%
2,874
-27.7%
0.14%
+82.3%
Q4 2022$151,010
+65.9%
3,975
+10.3%
0.08%
+119.4%
Q3 2022$91,000
-16.5%
3,604
+0.7%
0.04%
-10.0%
Q2 2022$109,000
-38.1%
3,579
-33.3%
0.04%
-49.4%
Q1 2022$176,000
+17.3%
5,364
-5.6%
0.08%
+38.6%
Q4 2021$150,0000.0%5,684
+282.5%
0.06%
-13.6%
Q3 2021$150,000
-32.1%
1,486
-4.7%
0.07%
-27.5%
Q2 2021$221,000
-12.6%
1,560
-38.5%
0.09%
-15.0%
Q1 2021$253,000
-18.1%
2,537
+1.6%
0.11%
-16.4%
Q4 2020$309,000
+67.9%
2,498
+32.0%
0.13%
+32.0%
Q3 2020$184,000
-45.1%
1,893
-11.8%
0.10%
-39.0%
Q2 2020$335,000
+33.5%
2,146
+23.5%
0.16%
+54.4%
Q1 2020$251,000
-38.3%
1,738
-12.8%
0.10%
+53.7%
Q4 2019$407,000
+63.5%
1,992
-35.8%
0.07%
+34.0%
Q3 2019$249,000
-19.4%
3,101
-5.3%
0.05%
-23.1%
Q2 2019$309,000
-17.8%
3,273
-25.5%
0.06%
-91.9%
Q1 2019$376,000
+35.3%
4,396
-11.3%
0.80%
+1566.7%
Q4 2018$278,000
-71.5%
4,956
-58.5%
0.05%
-52.5%
Q3 2018$976,000
+36.3%
11,939
-41.7%
0.10%
-84.0%
Q2 2018$716,000
+16.0%
20,484
-31.9%
0.63%
+18.3%
Q1 2018$617,000
+56.6%
30,088
+116.2%
0.54%
+8.3%
Q4 2017$394,000
-2.0%
13,917
+7.7%
0.49%
+814.8%
Q3 2017$402,000
+8.1%
12,925
+10.1%
0.05%
-3.6%
Q2 2017$372,000
+27.4%
11,743
-9.0%
0.06%
+7.7%
Q1 2017$292,000
+14.5%
12,909
+10.6%
0.05%
-31.6%
Q4 2016$255,00011,6720.08%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders